• Gates Foundation in Venture Capital Shift

    Financial Times | The Gates Foundation plans to take equity stakes in up to a dozen biotech companies this year, signalling a shift towards a “venture capital” approach at the world’s biggest philanthropic organisation.

    Jun 27, 2012

  • Qiagen Eyes Clinical NGS Market in Acquiring Intelligent Biosystems

    Bio-IT World | Intelligent Biosystems (IBS), a privately held next-gen sequencing (NGS) company based in Waltham, Mass., has been acquired by molecular diagnostics company Qiagen, signaling a concerted move to integrate clinical NGS testing into the German company’s diagnostics portfolio. 

    Jun 26, 2012

  • Global Governments' Growing Embrace of Big Pharma

    Real Clear Markets | Bill Frezza, a.k.a. author of Bio-IT World's "The Skeptical Outsider" column, pens a scathing dispatch from last week's BIO convention in Boston. "Music, food, and drink abounded, served out of booths with carpets so plush you had to watch your footing. Each was copiously staffed with representatives flown in from around the world busy selling ... well, what? To whom? Using whose money? Toward what end?"

    Jun 25, 2012

  • Veteran Biotech Investor Kevin Kinsella Talks Genes, Drugs, and Musicals

    U-T San Diego | Kevin Kinsella, the veteran San Diego-based biotech investor, is as much about musicals and social networking these days as personalized medicine. "Getting your complete genome sequenced, to find genotypic traits that are going to tell you more about your health? It won’t do us much good, and, frankly, I don’t think people really care.”

    Jun 25, 2012

  • DNA of Wellderly May Hold Clues to Complex Disease

    SF Gate | Scientists are taking a deep look at the genetics of unusually healthy elderly individuals to see if there's something protecting them from common illnesses such as Alzheimer's, cancer, diabetes and heart disease -- or what Eric Topol, director of the Scripps Translational Science Institute, calls "Teflon-coated" genes

    Jun 25, 2012

  • The (Genomics) View From the 57th Floor

    Gigablog | The editors of the journal GigaScience offer their appraisal of the inaugural Bio-IT World Asia conference, held earlier this month in Singapore. "The meeting's proximity to the Singapore Biopolis ... and its location at the 57-story Marina Bay Sands resort (with its rooftop world's highest infinity pool) were a winning combination in getting an impressive mix of scientists from around the Asia-Pacific and beyond... to attend and present."

    Jun 25, 2012

  • Experts Discuss Future of Medicine at Israeli Presidential Symposium

    Jerusalem Post | Experts including USC professor and Navigenics co-founder David Agus discussed topics such as the stagnation in drug development and the future of medicine at the Israeli presidential symposium this week.

    Jun 22, 2012

  • Cancer, Data and the Fallacy of the $1000 Genome

    Forbes.com | In his first "Hacking Healthcare" blog, Jim Golden discusses the central theme of a recent talk by pathologist Mark Boguski. "The time of the $1,000 genome meme is over," he writes. "It served us well for years... but now it is reducing clinical credibility.  It’s time for it to leave the lexicon of healthcare; it has to go." 

    Jun 22, 2012

  • Massachusetts Researchers Win $100K Paul Janssen Award

    Mass High Tech | Victor Ambros (University of Massachusetts Medical School) and Gary Ruvkun (Massachusetts General Hospital) will share the 2012 $100,000 Dr. Paul Janssen Award for Biomedical Research from Johnson & Johnson for the discovery of microRNAs

    Jun 20, 2012

  • Toronto’s Hospital for Sick Children Selects Ion Proton in Whole Genome Sequencing Push

    Bio-IT World | Toronto's Hospital for Sick Children will feature the Ion Proton sequencer as part of a major push into whole-genome sequencing at a new center for genetic medicine, aiming to sequence up to 10,000 patients annually in the coming years. 

    Jun 20, 2012

  • Open Access is Future of Academic Publishing, says UK Report

    The Guardian | "The future lies with open access publishing," says the chair of a new UK report on expanding access to publicly funded research, published this week. "The UK should recognise this change, should embrace it and should find ways of managing it in a measured way."

    Jun 20, 2012

  • IBM Blue Gene Reclaims Pole Position in TOP500 HPC Rankings

    HPC Wire | A 16-PetaFlop IBM Blue Gene/Q computer, Sequoia, has knocked off Japan's K Computer in the latest TOP500 rankings of high-performance computers, released at the International Supercomputing Conference in Hamburg, Germany.

    Jun 19, 2012

  • Pacific Biosciences Releases Epigenetics Software

    Bio-IT World | Pacific Biosciences has released new software for identifying epigenetic modifcations in DNA, which could provide an important advance in studying the chemical modulation of gene activity in health and disease.

    Jun 19, 2012

  • Tending the Body's Microbial Garden

    New York Times | Scientists are making big strides in documenting the medical ecology of the microbiome -- the 100 trillion microbes that make human beings their home.

    Jun 19, 2012

  • NYGC Eyes Permanent Home in Manhattan

    Wall Street Journal | The New York Genome Center is in the final stages of negotiating a deal for about 150,000 square feet at 101 Sixth Ave., in the SoHo neighborhood of Manhattan, signaling the home stretch for the center's six-month search for a permanent home.

    Jun 18, 2012

  • Ambry Genetics Catches the Clinical Sequencing Wave

    Bio-IT World | After launching its CLIA Exome sequencing service six months ago, Ambry Genetics has quietly dropped the price to $7,900 for a trio. But potentially cannabilizing a thriving molecular diagnostics business is far from the only thing that makes Ambry stand out.  

    Jun 12, 2012

  • Finish What We Started: Dietrich Stephan’s Silicon Valley Biosystems Opens Genome Interpretation Floodgates

    Bio-IT World | In an exclusive briefing with Bio-IT World, the co-founder of Navigenics, Dietrich Stephan, says he aims to “finish what we started” with the commercial launch of a new genome interpretation company, Silicon Valley Biosystems (SVBio). 

    Jun 12, 2012

  • June Free Trials and Downloads

    Bio-IT World | Free trials and downloads for June.

    Jun 11, 2012

  • Foundation Medicine, Novartis Partner for Clinical Trial Enrollment

    Foundation Medicine | Foundation Medicine and Novartis are partnering on cancer drug testing. Novartis plans to use Foundation's technology as part of its cancer trial enrollment process over the next three years, focusing on Phase 1 and 2 oncology clinical programs. 

    Jun 10, 2012

  • FDA Delays Decision on HIV Pill

    San Francisco Chronicle | FDA has announced a delay in its decision on Gilead Sciences' HIV-prevention pill, choosing to take another three months to review the application and supporting materials.

    Jun 10, 2012